Simply log in to access the full post.
Read the full story here: What GLP1 users need: Food, nutrition and CPG innovation Nestl signals strategic reset in a shifting market The last month marked a critical moment for Nestl, as its CEO Phillip Navratil outlined a broader strategic overhaul aimed at sharpening focus, restoring growth and responding to changing consumer demand
This report provides an exhaustive analysis of GLP-1 drug manufacturing as of 2026, covering historical context, current expansions, CDMO strategies, tech-transfer practices, and future directions
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinsons disease: variation by age, gender, and race/ethnicity